PIM
ARIA

Parasol Investment Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Parasol Investment Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-133
Closed -$1K – 324
2014
Q3 		$1K Hold
133
– – ﹤0.01% 287
2014
Q2 		$1K Hold
133
– – ﹤0.01% 271
2014
Q1 		$1K Hold
133
– – ﹤0.01% 255
2013
Q4 		$1K Buy
+133
New +$718 ﹤0.01% 257

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Parasol Investment Management's ARIA Position: Q4 2014 in Review

Parasol Investment Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2014, closing a stake of 133 shares — an estimated $1K sold.

Parasol Investment Management first reported a position in ARIA in Q4 2013 and held it in 4 quarters. The position peaked at $1K in Q3 2014. 179 funds tracked by Wall St. Rank hold ARIA as of Q4 2014.

  • Parasol Investment Management reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • Parasol Investment Management sold 133 Ariad Pharmaceuticals Inc shares in Q4 2014, an estimated $1K.
  • Parasol Investment Management first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 4 quarters.
  • Parasol Investment Management's Ariad Pharmaceuticals Inc position peaked at $1K in Q3 2014.
  • 179 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2014.

Based on Parasol Investment Management's 13F filing for Q4 2014, filed 15 May 2015.